METROPOLITAN LIFE INSURANCE CO/NY - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 214 filers reported holding IMMUNOGEN INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$221,847
-10.8%
13,979
+6.0%
0.01%0.0%
Q2 2023$248,782
+521.3%
13,184
+26.4%
0.01%
+500.0%
Q1 2023$40,040
-37.6%
10,427
-19.4%
0.00%
-33.3%
Q4 2022$64,143
+3.8%
12,9320.0%0.00%0.0%
Q3 2022$61,815
+34.8%
12,932
+26.9%
0.00%
+50.0%
Q2 2022$45,873
-24.3%
10,194
-19.9%
0.00%0.0%
Q1 2022$60,561
-84.2%
12,723
-75.4%
0.00%
-60.0%
Q4 2021$383,644
+33.5%
51,704
+2.0%
0.01%
+25.0%
Q3 2021$287,327
+1.2%
50,675
+17.6%
0.00%0.0%
Q2 2021$284,016
-28.3%
43,098
-11.9%
0.00%
-33.3%
Q1 2021$396,033
+20.4%
48,893
-4.2%
0.01%
+20.0%
Q4 2020$329,047
+115.7%
51,015
+20.4%
0.01%
+66.7%
Q3 2020$152,561
-39.3%
42,378
-22.4%
0.00%
-25.0%
Q2 2020$251,280
+34.8%
54,626
-0.1%
0.00%0.0%
Q1 2020$186,469
-21.2%
54,683
+18.0%
0.00%0.0%
Q4 2019$236,622
+100.8%
46,351
-4.8%
0.00%
+100.0%
Q3 2019$117,852
+11.5%
48,6990.0%0.00%0.0%
Q2 2019$105,677
-5.7%
48,699
+17.7%
0.00%0.0%
Q1 2019$112,115
-50.3%
41,371
-12.0%
0.00%
-60.0%
Q4 2018$225,682
-49.3%
47,0170.0%0.01%
-37.5%
Q3 2018$445,251
-99.9%
47,017
+11.4%
0.01%
+14.3%
Q2 2018$410,538,000
+16.0%
42,193
+25.4%
0.01%
+40.0%
Q1 2018$353,998,000
+183318.7%
33,650
+11.8%
0.01%
+66.7%
Q4 2017$193,000
-61.6%
30,098
-54.2%
0.00%0.0%
Q3 2017$502,000
+6.1%
65,678
-1.3%
0.00%0.0%
Q2 2017$473,000
+84.0%
66,5170.0%0.00%
+50.0%
Q1 2017$257,000
+59.6%
66,517
+11.0%
0.00%
+100.0%
Q3 2016$161,000
-24.1%
59,929
-13.1%
0.00%
-50.0%
Q2 2016$212,000
-63.9%
68,9500.0%0.00%
-60.0%
Q1 2016$587,000
-28.1%
68,950
+14.7%
0.01%
-16.7%
Q4 2015$816,000
+41.4%
60,1020.0%0.01%
+50.0%
Q3 2015$577,000
-38.6%
60,102
-8.0%
0.00%
-42.9%
Q2 2015$940,000
+51.6%
65,339
-5.7%
0.01%
+40.0%
Q1 2015$620,000
+46.6%
69,289
-0.2%
0.01%
+66.7%
Q4 2014$423,000
-42.4%
69,4020.0%0.00%
-40.0%
Q3 2014$735,000
-10.6%
69,4020.0%0.01%
-16.7%
Q2 2014$822,000
-20.7%
69,4020.0%0.01%
-14.3%
Q1 2014$1,036,000
+1.8%
69,4020.0%0.01%0.0%
Q4 2013$1,018,000
-13.8%
69,4020.0%0.01%
-22.2%
Q3 2013$1,181,000
+2.6%
69,4020.0%0.01%0.0%
Q2 2013$1,151,00069,4020.01%
Other shareholders
IMMUNOGEN INC shareholders Q4 2020
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 600,000$3,870,0002.25%
CM Management, LLC 375,000$2,419,0002.24%
Consonance Capital Management LP 3,515,944$22,678,0002.12%
RA Capital Management 18,417,458$118,793,0001.66%
Kercheville Advisors, LLC 244,421$1,564,0000.85%
Redmile Group, LLC 10,528,179$67,907,0000.82%
Birchview Capital, LP 190,000$1,226,0000.71%
QVT Financial LP 1,375,900$8,875,0000.49%
Fernwood Investment Management, LLC 149,340$963,0000.38%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$671,0000.21%
View complete list of IMMUNOGEN INC shareholders